Genetic epidemiologic studies often involve investigation of the association of a disease with a genomic region in terms of the underlying haplotypes, that is the combination of alleles at multiple loci along homologous chromosomes. In this article, we consider the problem of estimating haplotype-environment interactions from case-control studies when some of the environmental exposures themselves may be influenced by genetic susceptibility. We specify the distribution of the diplotypes (haplotype pair) given environmental exposures for the underlying population based on a novel semiparametric model that allows haplotypes to be potentially related with environmental exposures, while allowing the marginal distribution of the diplotypes to maintain certain population genetics constraints such as Hardy-WeinbergEquilibrium. The marginal distribution of the environmental exposures is allowed to remain completely nonparametric. We develop a semiparametric estimating equation methodology and related asymptotic theory for estimation of the disease odds-ratios associated with the haplotypes, environmental exposures and their interactions, parameters that characterize haplotype-environment associations and the marginal haplotype frequencies. The problem of phase-ambiguity of genotype data is handled using a suitable Expectation-Maximization algorithm. We study the finite sample performance of the proposed methodology using simulated data. An application of the methodology is illustrated using a case-control study of colorectal adenoma, designed to investigate how the smoking-related risk of colorectal adenoma can be modified by NAT2, a smoking-metabolism gene that may potentially influence susceptibility to smoking itself.
Introduction
Genetic epidemiologic studies often involve investigation of the association between a disease and a candidate genomic region of biologic interest. Typically, in such studies, genotype information is obtained on multiple loci that are known to harbor genetic variations within the region of interest. An increasingly popular approach for analysis of such multi-locus genetic data are haplotype-based regression methods where the effect of a genomic region on disease-risk is modelled through "haplotypes", the combinations of alleles (gene-variants) at multiple loci along individual homologous chromosomes. It is believed that association analysis based on haplotypes, which can efficiently capture inter-loci interactions as well as "indirect association" due to linkage-disequilibrium of the haplotypes with unobserved causal variant(s), can be more powerful than more traditional locus-by-locus methods (Schaid, 2004) .
A technical problem for haplotype-based regression analysis is that in traditional epidemiologic studies the haplotype information for the study subjects is not directly observable.
Instead, locus-specific genotype data are observed, which contain information on the pair of alleles a subject carries on his/her pair of homologous chromosomes at each of the individual loci, but does not provide the "phase information", that is which combinations of alleles appear across multiple loci along the individual chromosomes. In general, the genotype data of a subject will be phase-ambiguous whenever the subject is heterozygous at two or more loci. Statistically, the lack of phase information can be viewed as a special missing data problem.
Recently, a variety of methods have been developed for haplotype-based analysis of casecontrol data using the logistic regression model (Zhao, Li and Khalid, 2003; Lake et al, 2003; Epstein and Satten, 2003; Satten and Epstein, 2004; Spinka, Carroll and Chatterjee, 2005; Lin and Zeng, 2006, Chatterjee et al., 2006) . Two classes of methods, namely "prospective" and "retrospective" have evolved. Prospective methods ignore the retrospective nature of the case-control design. In the classical setting, without any missing data, justification of prospective analysis of case-control data relies on the well known result about the equivalence of prospective and retrospective likelihoods under a semiparametric model that allows the distribution of the underlying covariates to remain completely nonparametric (Andersen, 1972; Prentice and Pyke, 1979) . Even with missing data, the equivalence of the prospective and retrospective likelihood may hold, provided the covariate distribution is allowed to remain unrestricted (Roeder, Linndsay and Carroll, 1996) . For haplotype-based genetic analysis, however, complete nonparametric treatment of the covariates, including haplotypes, may not be possible due to intrinsic identifiability issues for the phase ambiguous genotype data (Epstein and Satten, 2003) . Thus, in this setting, the proper retrospective analysis of case-control data requires special attention.
An attractive feature of the retrospective likelihood is that it can enhance efficiency of case-control analysis by directly incorporating certain type of covariate distributional constraints that are natural for genetic epidemiologic studies. The assumptions of HardyWeinberg-Equilibrium (HWE) and gene-environment independence are two prime examples of such constriants. The HWE model, which specifies simple relationships between allele and genotype frequencies at a given chromosomal locus, or between haplotype and diplotype (pair of haplotypes on homologous chromosomes) frequencies across multiple loci, is a natural law for a random mating large stable population. Often, it is also natural to assume that a subject's genetic susceptibility, a factor which is determined at birth, is independent of his/her subsequent environmental exposures. However, if these assumptions are violated in some situations, then retrospective methods can produce serious bias in odds ratio estimates (see e.g. Satten and Epstein, 2004; Chatterjee and Carroll, 2005; Spinka, et al., 2005) . Thus, there is a need for alternative flexible models for specifying the joint distribution of genetic and environmental covariates that could be used to assess the sensitivity of the retrospective methods to underlying assumptions as well as to develop alternative robust methods.
Both Satten and Epstein (2004) and Lin and Zeng (2006) have described retrospective maximum-likelihood analysis of case-control data under flexible population genetics models that can relax the HWE assumption. Moreover, Lin and Zeng considered a model that allows the joint distribution of unphased genotypes and environmental exposure to remain completely nonparametric, but they assumed conditional independence between haplotypes and the environmental factors given the unphased genotypes. If, however, it is the underlying biologic units through which a mechanism of gene is determined, then it is more natural to allow for direct association between haplotypes and environmental exposures. Moreover, if such association could exist, then quantifying the association between haplotypes and certain type of environmental exposures, such as lifestyle and behaviorial factors, would be of scientific interest.
In this article, we propose methods for retrospective analysis of case-control data using a novel model for the gene-environment distribution that can account for direct association between haplotypes and environmental exposures. The model is developed in Section 2. We assume a standard logistic regression model to specify the disease risk conditional on diplotypes and environmental exposures. In addition, we assume a polytomous logistic regression model for specifying the population distribution of the diplotypes conditional on the environmental exposures, with the intercept parameters of the model specified in such a way that the marginal distribution of the diplotypes can follow certain population genetic constraints such as HWE. Moreover, by exploiting the equivalence of prospective and retrospective oddsratios under the polytomous regression model, we further incorporate certain constraints on the diplotype-exposure odds-ratio parameters that could reflect specific "mode of effects" for the haplotypes. We allow the marginal distribution of the environmental exposure to remain completely nonparametric.
Under the proposed modelling framework, we then describe in Section 3 a "semiparametric" estimating equation method for inference about the finite dimensional parameters of interest, namely the disease odds-ratios, haplotype frequencies and haplotype-exposure odds-ratios. We develop a suitable expectation-maximization (EM) algorithm to account for the phase-ambiguity problem. We study asymptotic theory of the proposed estimator under the underlying semiparametric setting.
In Section 4, we assess the finite sample performance of the proposed estimator based on case-control data that were simulated utilizing haplotype patterns and frequencies obtained from a real study. In Section 5, we apply the proposed methodology to a case-control study of colorectal adenoma to investigate whether certain haplotypes in the smoking metabolism gene, NAT2, could modify smoking-related risk of colorectal adenoma and whether the same haplotypes could influence an individual's susceptibility to smoking as well. Section 6 contains concluding remarks. All technical details are in an Appendix. A SAS macro is available on request to implement the methodology.
Notation and Proposed Model
For haplotype-based studies, the underlying genetic covariate for a subject is defined by "diplotypes", that is, the two haplotypes the individual carries in his/her pair of homologous chromosomes, where each "haplotype" is the combination of alleles at the loci of interest along an individual chromosome. Following the notation developed in Spinka et al. (2005) 
The diplotype data however, is not directly observable. Instead, for each subject, the multi-locus genotype data G is observed, which contains information on the pair of alleles the individual carries at each individual locus, but does not provide the "phase information", that is which combination of alleles appears along each of the individual chromosomes. Thus, the same genotype data G could be consistent with multiple diplotypes. We will denote C (G) to be the set of all possible diplotypes that are consistent with the genotype data G.
Given the diplotype data H di and a set of environmental covariate X, we assume that the risk of the disease is given by the logistic regression model
for some known function m(·, β 1 ). Often one further imposes structural assumptions on the odds-ratio parameters β 1 by modelling the effect of the diplotypes through constituent haplotypes according to a dominant, additive or recessive mode of effect (Wallenstein, Hodge, and Weston, 1998) . For example, a logistic regression model which assumes an additive effect for each copy of a haplotype corresponds to
where β X is the main effect of X, β h j k is the main effect of haplotype h j k , k = 1, 2 and β h j k :X is the interaction effect of X with haplotype h j k , k = 1, 2. Such modelling may be necessary due to identifiability considerations (Epstein and Satten, 2003) 
where with the odds-ratio parameters of the disease-risk using the profile-likelihood approach developed by Chatterjee and Carroll (2005) . In the presence of phase-ambiguity, however, the diplotypes being not directly observable, further constraints on the parameters γ 0 and γ 1 are needed for the purpose of identifiability. In the following, we show how certain natural genetic models can be used to impose these constraints.
Given that genetic susceptibility may influence environmental exposures and not vice versa, for causal interpretation of parameters it is more natural to consider a model for the environmental exposures given the diplotypes. However, the odds-ratios associated with the distributions [X|H] and [H|X] being the same, the parameters in γ 1 can be interpreted as measures of "diplotype effects" on the distribution of exposure. Thus, it is natural to specify the γ 1 -parameters according to certain "mode of effects" of the underlying haplotypes. For example, assuming an "additive" effect for the haplotypes, one can write
which allows the diplotype-effects to be determined by a reduced set of "haplotype-effect" parameters γ 1,j ; in this case γ 1 would denote the vectorized form for the parameters γ 1,j .
Similarly, other commonly used models, such as "dominant" or "recessive" models, could be used to impose natural constraints on the γ 1 -parameters in model (3). We also observe that the parametric model (3), combined with the nonparametric distribution F (x), imposes a semiparametric model on the distribution of [X|H] with a density
.
This class of semiparametric models includes the parametric sub-model where X|H
follows a multivariate normal distribution with mean µ h di and common variance-covariance matrix Σ. In this case, is easy to see that
, which is a measure of the shift in the mean of the distribution of X due to differences in the diplotypes.
The parameter γ 0 in model (3) defines the population diplotype frequencies for a baseline value of the exposure X. It is common to use population genetics models, such as HWE, to specify a relationship between diplotype and haplotype frequencies. However, observe that if the diplotypes can influence certain environmental exposures, then the frequencies of the diplotypes within exposure categories may not follow the HWE constraints although the underlying population, as a whole, may be in HWE. Thus, the population-level marginal haplotype-pair distribution is assumed to follow HWE and is characterized by the parameters
where h 1 denotes the chosen reference haplotype and θ 1 = 0. Let
be the marginal frequency for the diplotype h di . Recall that in the proposed model, γ 0 is defined as an implicit function of γ 1 , θ and F (x) through the relationship
Note that F is left as unspecified and hence the model proposed is semiparametric.
Semiparametric Estimating Equation Inference

Estimation with Known Haplotypes
In what follows, where there can be no confusion, we will write h for h di .
Let H(x) = exp(x)/{1 + exp(x)} be the logistic distribution function. Write the risk model probability as
that is specified as in (3).
To start with, consider the ideal case that the phase information is known so that H di is observed. Since F is treated nonparametrically, assume that F is discrete and has mass
in the case-control sample. Let n dkh be the number of subjects in the sample with (D =
Ignoring the dependence of γ 0 on F tentatively, the loglikelihood of the case-control data can then be written as
Maximizing l with respect to δ for fixed values of ω = (β, γ 0 , γ 1 ) then leads to
and the profile log-likelihood
where
The calculation is similar to that in Chatterjee and Carroll (2005) .
As noted by Chatterjee and Carroll (2005) , the parameter β 0 is separable from κ and hence is theoretically identifiable. In practice, however, there is usually little information about β 0 available in the observed data and hence the information matrix is nearly singular.
One way to bypass this problem is to use external information on the disease prevalence pr(D = 1), while another way is to use the rare-disease approximation when the disease is rare. The estimation method described below can be applied to both the two cases of pr(D = 1) being known and the rare-disease approximation being made, with suitable definitions on B and S(d, h, x, B, γ 0 , γ 1 ). When pr(D = 1) is known, κ depends on β 0 only, hence here we define B = (β 0 , β 1 )
T . When the disease is rare so that
we have
Note that β 0 does not appear in this expression and hence we define B = (κ, β 1 )
Our goal is to estimate the parameters (B, θ, γ 1 ) based on the profile log-likelihood (7), where γ 0 is defined as an implicit function of (θ, γ 1 , F ) through (5), and we write
L Φ (·) be respectively the derivatives of L(·) with respect to Ω and Φ, and G θ and G γ 1 the derivatives of G(·) with respect to θ and γ 1 . We then have
Explicit expressions for G γ 1 and G θ are given in Appendix A.3. Also, the information matrix is given by
, with L ΩΩ the second derivative of L with respect to Ω; note that the terms involving second derivatives of Ω * do not appear in the information matrix because E(L Ω ) = 0, which is a direct consequence of the Lemmas 1 and 2 in the Appendix. We
propose to obtain the estimate of Φ by solving the estimating equation
where we have substituted an estimate F for F in G(·); that is, for each fixed value of (θ, γ 1 ),
One convenient choice of F is the empirical estimate F emp , which is given by
for the case where pr(D = 1) is known, where F emp,1 (x) and F emp,0 (x) are the empirical distributions of X in the case and in the control samples, and is given by
for the case where the rare-disease assumption can be made. An alternative choice of F (x)
would be the profile-likelihood estimate (6). Numerical calculations not given here show that the latter choice, requires more computational efforts while yielding results very similar to those given by the empirical estimate F emp .
Estimation with Ambiguous Haplotype Data
Now we turn to the more practical case where the haplotype data cannot be observed directly and must be inferred from the unphased genotype data, that is, the haplotype information may be subject to ambiguity. In this case, we apply an EM-like algorithm to the "completedata" estimating equation (9). Let G i denote the observed unphased genotype of subject i, and C(G i ) the set of diplotypes that are consistent with
is observed for each subject, we propose to obtain the estimate Φ for Φ = (B, γ 1 , θ) as the solution of the weighted version of (9):
where using the short-hand notation that γ 0 = G(θ, γ 1 , F emp ), the weights are given by
The limiting version of the weights is given as
Solving the estimating equation (11) can be implemented simply by an EM-like algorithm as follows. Starting with an initial value for Φ and hence an initial value for γ 0 , we (i) calculate the weights { w i } from (12);
(ii) solve (11) to obtain an updated estimate of Φ using the weights { w i } given in (i); note that within this step we also need to solve (10) to obtain updated value of γ 0 ;
The algorithm is iterated between the two steps until convergence. Note that the weights { w i } are only used in solving Φ from (11) and are not required in solving γ 0 from (10).
Asymptotic Theory
Make the following series of definitions. Expectations denoted as E cc (·) are taken under the case-control sampling design, i.e., for any random vector
Note that the second derivative of Ω * does not appear in I since E(L Φ ) = E(L Φ ) = 0, and the last identity in (14) is given by Lemma 3 in the Appendix.
Define p emp (D i ) to be the mass of F emp (X i ), which is equal to
is known and is equal to I(D i = 0)/n 0 when the rare disease approximation is used.
Let q hap (X, γ 1 , γ 0 ) = {q hap (h|X, γ 1 , γ 0 )} be the vector-collection over h of q hap (h|X, γ 1 , γ 0 ) for all diplotypes except the reference diplotype, and let q HWE (θ) be defined similarly. Define
where I Ωγ 0 is the obvious sub-matrix of I ΩΩ .
Suppose that E cc {E(·)E T (·)} exists and that the matrix I is invertible. Then n 1/2 ( Φ − Φ) is asymptotically normal with mean zero and covariance matrix
Remark 1 The asymptotic variance Γ can be readily estimated by replacing each component matrix with its empirical counterpart. Lemma 3 gives useful expressions to facilitate this computation.
Remark 2 In our numerical experiments, the estimated covariance based on formula (15) is very close to that based on the "naive" covariance estimate obtained by naively treating the estimating equation (11) 
Whether this naive estimate performs well in general is unknown and we suggest using the estimate based on (15).
Simulations
Finite Sample Performance under Correct Model
In this section, we study the finite sample performance of the proposed estimator using simulated data generated under the proposed modelling framework. We simulated haplotypes following published data (Epstein and Satten, 2003) on haplotype patterns and frequencies for five single neucleotide polymorphisms (SNP) in a putative susceptibility gene for diabetes (see Table 1 ). The simulations involved a single environmental covariate X, assumed to follow a standard normal distribution in the population. Given X, the diplotypes (haplotype-pair)
for an individual was generated from a polytomous logistic regression of the form (3), where the diplotype-specific odds-ratios were further specified according to an additive model of the form γ 1j 1 j 2 = γ 1,j 1 + γ 1,j 2 , where j 1 , j 2 denote the index for 14 haplotypes shown in Table   1 . We assume γ 1,4 = γ 1,5 = −0.4 and γ 1,12 = 0.4, and all the other γ 1,j = 0. The parameters γ 0j 1 j 2 s in model (3) are then specified in such a way that the marginal diplotype distribution follow HWE with haplotype-frequencies given in Table 1. For generating disease outcome, we chose the haplotype "01100" (j = 5) to be causal and used the logistic model
where Z(5) denote the number of the copies of the causal haplotype contained in H di . The true value of the parameter-vector (β 0 , β H , β X , β HX ) was set to (−3.0, 0.2, 0.1, 0.3). A case-control sample with 600 controls and 600 cases was then sampled. The results were based upon 1, 000 simulated data sets.
When analyzing the data, we only used the unphased genotype information. We did not assume the causal haplotype to be known. Thus, in both the disease-risk model (1) and the diplotype-frequency model (3), we choose the most common haplotype "10011" as a reference and estimated a separate regression parameter for each of the non-referent haplotypes. Since rare haplotypes may lead to unreliable estimates of the associated regression parameters, when estimating β and γ 1 , rare haplotypes with frequency < 1% are grouped into the reference haplotype. The resulting 8 grouped haplotypes are labelled as h j , j = 2, . . . , 8;
see Table 1 for details about how the haplotypes are grouped.
In each simulation, we obtain two sets of estimates from the proposed method, one using the rare-disease approximation (8) and the other using the known value of the population disease prevalence. Results shown in Table 2 show that both sets of estimates are essentially unbiased. Also, the standard error estimates are in close agreement with the true values, and the coverage probabilities are close to the nominal value (95%). As expected, the estimates for θ and γ 1 are generally more efficient using external information on the disease prevalence than when using the rare-disease approximation, but no such efficiency gain is observed for the parameters β in the disease risk model. Similar conclusion can be drawn from the simulations with a bernoulli covariate (success probability=0.5), showing the applicability of the proposed method to the categorical covariate. Detailed results for this set of simulations are included in the supplementary material (BIOSTATISTICS WEBSITE).
Model Robustness
Here we consider a simulation study where we generate the data in such a way that the polytomous model for diplotype-frequencies may not exactly hold. 
where the diplotype data are again generated from the distribution in Table 1, 
, using the method proposed by Spinka et al. (2005) . The rare-disease approximation is made when applying both the two methods.
The results shown in Table 3 reveal that, for the estimation of the association parameters β, the proposed method may be quite robust to modest misspecification of the model for 5 Case-Control Study of Colorectal Adenoma Study,
NAT2-haplotype and Smoking
We illustrate the proposed modelling and estimating methodologies with an application to a case-control study of colorectal adenoma, a precursor of colorectal cancer. The study involved 628 prevalent advanced adenoma cases and 635 gender-matched controls, selected from the screening arm of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial at the National Cancer Institute, USA (Gohagan et al., 2000; Moslehi et al., 2006) . One of the main objectives of this study is to assess whether smoking-related risk of colorectal adenoma may be modified by certain haplotypes in NAT2, a gene known to be important in metabolism of smoking related carcinogens. In addition, since NAT2 is involved in the smoking metabolism pathway, potentially it can influence an individual's addiction to smoking. Thus, it was also of interest to identify potential haplotypes that could influence an individual's susceptibility to smoking.
Genotype data were available on six SNPs. We initially applied the EM algorithm proposed by Li et al. (2003) for haplotype-frequency estimation to derive 7 common haplotypes with estimated frequency greater than 0.5%, which are then included in our association analysis with the most frequent haplotype served as the reference haplotype. Subjects were categorized as "never", "former" or "current" smokers. We fit a logistic regression model (1) assuming an additive effect for each haplotype other than the reference one; see (2). The haplotype-environment interaction terms include only those for the haplotype "101010" with Smk1 and Smk2, two dummy variables for "former" and "never" smokers, because they are the only promising interactions according to preliminary analysis. The disease-risk model was further adjusted for Age, recorded in years, and Gender. A polytomous logistic regression (3) is specified for the conditional distribution of diplotypes given the environmental covariates Smk1 and Smk2 with the marginal diplotype distribution being specified by the HWE constraints. The main parameters of interest include the disease-haplotype odds ratio parameters β 1 , the haplotype-environment odds ratio parameters γ 1 , and the marginal haplotype frequencies in the whole population. The marginal distribution for the environmental covariates is left unspecified. For estimation of regression parameters β and γ 1 , we grouped haplotypes with frequency less than 2% into the reference haplotype. The rare-disease approximation was made in deriving the estimating equation, and the EM algorithm proposed in Section 3 is utilized to accommodate the unphased genotype data.
Results from this application are displayed in Table 4 . It is clear that current smokers can have significantly elevated risk for colorectal adenoma relative to non-smokers, adjusting for gender and age. Relative to the reference haplotype "001100", all the other haplotypes are associated with reduced risk for colorectal adenoma, but the statistical evidence is not significant. However, the significance of the interaction 101010×Smk2 suggests that smoking related risk of adenoma was much reduced for carriers of the haplotype "101010" than non-carriers. The finding is consistent with previous laboratory and epidemiologic studies that have identified the haplotype "101010", known as NAT2*4, as a rapid metabolizer for smoking related carcinogens. The estimates for the parameter γ 1 for the conditional diplotype distribution reveal that the susceptibility to smoking seems not to be influenced by any haplotypes we considered. Finally, the estimates for the marginal haplotype frequencies derived from the estimates of θ are quite close to those obtained by the EM algorithm of Li et al. (2003) applied to the genotype data of the controls.
To check if the analysis is sensitive to model specification for the conditional distribution of diplotypes given the environmental covariates, we further fit the model (3) 
Concluding Remarks
The model we have proposed for gene-environment association is suitable when the underlying haplotypes of a genomic region may causally influence the environmental exposure(s)
under study. The model, however, requires special treatment for environmental factors, such as ethnicity or geographic region(s), which may be associated with the genomic region under study, not because of any causal relationship, but merely due to population stratification.
Suppose, in addition to the main environmental exposure X, there is a set of environmental factors S which could be used to divide the underlying population into K strata that are likely to be genetically heterogenous. In such a situation, a natural model for describing the association between diplotypes H di and environmental factors W = (X, S) is given by
where the stratum-specific intercept parameters γ 0j 1 j 2 (S) should be specified in such a way that the diplotype-frequencies, after marginalized over X, follows population genetics con-straints, such as HWE, within each stratum defined by S. The disease-risk model could be also extended to include S as a risk-factor. 
Proof of Lemma 2: By definition
and direct calculation yields
which proves the result.
Lemma 3 provides explicit forms for the information matrices.
Lemma 3 Let
with respective to Ω, and
Proof of Lemma 3:
The first identity has been given in Lemma 4 of Chatterjee and Carroll (2005) . To show the second identity, applying the chain rule we have
The first term of (A.3) equals
By the definition of w(h, Ω) given in (13), it easy to see that
where the joint density p *
Hence the second term of (A.3) leads to
The desired result thus follows.
A.2 Proof of Theorem 1
We will first obtain the asymptotic expansion of the proposed estimating equation (11),
by which the large sample distribution theory for Φ can be derived immediately from the Central Limit Theorem.
For our estimator Φ = ( B, γ 1 , θ), a standard Taylor series expansion of (11) yields
In view of (5) and (10),
Recall that γ 0 is solved from the equation (10):
Making a further Taylor series expansion we have
Note that
An explicit expression for Q is given in Appendix A.3. Consequently, the middle two terms in the expansion (A.4) reduce to
Therefore, we have
Note that in the last equality above we have used the fact that
, which follow directly from Lemmas 1 and 2. This completes the proof.
A.3 Expressions for the Derivatives of
Recall that G(θ, γ 1 , F ) is the solution of γ 0 to the equation (5). Here we define γ 1 to be the vectorized form for the diplotype-effect parameters subject to certain mode of effects (e.g. additive effect) of haplotypes, and define η to be the vectorized form for the full set of diplotype effects {γ 1j 1 j 2 }. Differentiating both sides of (5) with respect to γ 1 we have
Similarly, letting
The derivatives of G(θ, γ 1 , F emp ) can be obtained by replacing dF in the above quantities with d F emp . Table 2 : Simulation results for the case with an additive genetic law. Here "Mean" is the mean over 1, 000 simulated data sets, "SE" is the standard deviation of the estimates, SE is the mean of the estimated standard deviation of the parameter estimates, and "CP" is the coverage probability of the 95% confidence interval.
pr ( Table 3 : Simulation results for the case a misspecified conditional diplotype distribution given covariates. Here"Mean" is the mean over 1, 000 simulated data sets, "SE" is the standard deviation of the estimates, SE is the mean of the estimated standard deviation of the parameter estimates, and "CP" is the coverage probability of the 95% confidence interval. 
